Unlock stock picks and a broker-level newsfeed that powers Wall Street.
BSE - Delayed Quote INR

Camlin Fine Sciences Limited (CAMLINFINE.BO)

Compare
150.50
-21.15
(-12.32%)
At close: April 4 at 3:29:50 PM GMT+5:30
Loading Chart for CAMLINFINE.BO
  • Previous Close 171.65
  • Open 172.50
  • Bid 150.65 x --
  • Ask 149.85 x --
  • Day's Range 146.70 - 173.95
  • 52 Week Range 80.00 - 180.95
  • Volume 86,804
  • Avg. Volume 89,082
  • Market Cap (intraday) 28.282B
  • Beta (5Y Monthly) 0.46
  • PE Ratio (TTM) --
  • EPS (TTM) -12.48
  • Earnings Date May 19, 2025 - May 23, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date Jul 28, 2016
  • 1y Target Est 190.00

Camlin Fine Sciences Limited, together with its subsidiaries, engages in the research, development, manufacture, and marketing of specialty chemicals, ingredients, and additive blend products in India and internationally. The company offers shelf-life solutions, which include antioxidants comprises Butylated Hydroxy Toluene and Ascorbyl palmitate; and emulsifiers, mold inhibitors, antibacterial agents, toxin binders, pellet binders, disinfectants, energizers, preservatives, thickening agents, and growth promoters, as well as plant-based antioxidants, such as mixed tocopherols, green tea extract, and rosemary extract that are used to enhance the shelf life under the Xtendra and NaSure brands. It also provides aroma ingredients, including vanillin and ethyl vanillin; health and wellness products; and performance chemicals, such as hydroquinone and catechol. Its products are used in food and beverage, pet food, animal nutrition, rendering, health and wellbeing, chemicals, biofuel, aroma technical, fragrance, and flavor industries. The company was formerly known as Camlin Fine Chemicals Limited and changed its name to Camlin Fine Sciences Limited in August 2011. Camlin Fine Sciences Limited was founded in 1931 and is headquartered in Mumbai, India.

www.camlinfs.com

624

Full Time Employees

March 31

Fiscal Year Ends

Recent News: CAMLINFINE.BO

View More

Performance Overview: CAMLINFINE.BO

Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is S&P BSE SENSEX (^BSESN) .

YTD Return

CAMLINFINE.BO
14.71%
S&P BSE SENSEX (^BSESN)
3.55%

1-Year Return

CAMLINFINE.BO
52.22%
S&P BSE SENSEX (^BSESN)
1.53%

3-Year Return

CAMLINFINE.BO
3.58%
S&P BSE SENSEX (^BSESN)
24.34%

5-Year Return

CAMLINFINE.BO
262.65%
S&P BSE SENSEX (^BSESN)
173.15%

Compare To: CAMLINFINE.BO

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: CAMLINFINE.BO

View More

Valuation Measures

Annual
As of 4/4/2025
  • Market Cap

    28.35B

  • Enterprise Value

    34.99B

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.61

  • Price/Book (mrq)

    4.11

  • Enterprise Value/Revenue

    2.14

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -13.03%

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    16.54B

  • Net Income Avi to Common (ttm)

    -2.15B

  • Diluted EPS (ttm)

    -12.48

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    905.9M

  • Total Debt/Equity (mrq)

    115.27%

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: CAMLINFINE.BO

View More

Company Insights: CAMLINFINE.BO

Research Reports: CAMLINFINE.BO

View More

People Also Watch